Compare ABCL & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | IRMD |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 910.4M |
| IPO Year | 2020 | 2014 |
| Metric | ABCL | IRMD |
|---|---|---|
| Price | $3.55 | $96.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.75 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 3.6M | 83.8K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | N/A | ★ 1.65 |
| Revenue | $35,325,000.00 | ★ $80,511,268.00 |
| Revenue This Year | $25.45 | $15.17 |
| Revenue Next Year | $10.07 | $10.15 |
| P/E Ratio | ★ N/A | $56.99 |
| Revenue Growth | 7.17 | ★ 12.91 |
| 52 Week Low | $1.89 | $47.48 |
| 52 Week High | $6.52 | $98.44 |
| Indicator | ABCL | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 65.29 |
| Support Level | $3.32 | $93.06 |
| Resistance Level | $3.86 | $98.37 |
| Average True Range (ATR) | 0.19 | 2.29 |
| MACD | 0.04 | -0.41 |
| Stochastic Oscillator | 37.96 | 69.08 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.